When research involving the human person is conducted in an establishment with an in-house pharmacy, the sponsor must provide the pharmacist in charge of the pharmacy with the following information beforehand:
1° The title and objective of the research ;
2° Where applicable, the information mentioned in 2°, 3° and 4° of article R. 5121-15 for research involving an investigational medicinal product;
3° Where applicable, the investigator’s brochure referred to in article R. 1123-20 ;
4° Where applicable, the elements of the research protocol relevant to the possession, preparation, reconstitution, use and dispensing of the medicinal products and products required for the research;
5° The identity of the investigator(s) and the location(s) concerned in the establishment;
6° The date on which it is planned to start the research and the anticipated duration of the research.
The sponsor must send the pharmacist responsible for managing the project any updates to the information initially provided.